AstraZeneca
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
Drug Interaction Study Between AZD3355 and Nexium
- Conditions
- Gastroesophageal Reflux Disease
- Interventions
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2010-12-03
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 30
- Registration Number
- NCT00684190
- Locations
- 🇸🇪
Research Site, Uppsala, Sweden
Prevention of Stroke and Systemic Embolic Events in Patients With Atrial Fibrillation
- Conditions
- Nonvalvular Atrial Fibrillation
- Interventions
- Drug: AZD0837Drug: Vitamin-K antagonist at INR 2-3
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2012-03-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1084
- Registration Number
- NCT00684307
An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and Neck
- Conditions
- Non Small Cell Lung CancerCancer of the Head and Neck
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2019-03-14
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00684385
- Locations
- 🇬🇧
Research Site, Newcastle-upon-Tyne, United Kingdom
Add-on to Thiazolidinedione (TZD) Failures
- Conditions
- Type 2 Diabetes
- Interventions
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2017-02-23
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 972
- Registration Number
- NCT00683878
- Locations
- 🇺🇸
Diabetes Research Center, Tustin, California, United States
🇺🇸Endocrine Research Associates, Jackson, Mississippi, United States
🇺🇸Dallas Diabetes & Endocrine Center, Dallas, Texas, United States
Survey of Lipid Goal Attainment and Mortality in Patients With High Cardiovascular Risk in Thailand
- Conditions
- Dyslipidemia
- First Posted Date
- 2008-05-26
- Last Posted Date
- 2011-12-12
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1240
- Registration Number
- NCT00684151
- Locations
- 🇹🇭
Research Site, Maung, Uttaradit, Thailand
Compare the Efficacy of Rosuvastatin to Atorvastatin in High Risk Patients With Hypercholesterolemia
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2012-03-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 934
- Registration Number
- NCT00683618
- Locations
- 🇨🇳
Research Site, Tianjin, China
Safety and Efficacy Study of Subjects That Are Taking Saxagliptin Added Onto Metformin XR Compared to Subjects Taking Metformin XR Alone
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2015-06-01
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 93
- Registration Number
- NCT00683657
- Locations
- 🇺🇸
Endocrine Research Solutions, Inc., Roswell, Georgia, United States
🇺🇸Dedicated Phase I, Inc., Phoenix, Arizona, United States
🇺🇸Orange County Research Center, Tustin, California, United States
Open Label Extension Study With Gefitinib (IRESSA™) for Completing Trial Patients Who May Benefit From Further Treatment
- Conditions
- Non Small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2018-09-13
- Lead Sponsor
- AstraZeneca
- Registration Number
- NCT00683306
- Locations
- 🇹🇷
Research Site, İstanbul, Turkey
An Exploratory Trial of AZD3480 (TC-1734) for the Treatment of Adult Attention-Deficit/Hyperactivity Disorder (ADHD)
- Conditions
- ADHD
- Interventions
- Drug: PlaceboDrug: AZD3480
- First Posted Date
- 2008-05-23
- Last Posted Date
- 2009-10-30
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 24
- Registration Number
- NCT00683462
- Locations
- 🇺🇸
Research Site, Burlington, Vermont, United States
CARIATIDE (Compliance of ARomatase Inhibitors AssessmenT In Daily Practice Through Educational Approach)
- Conditions
- Breast Cancer
- First Posted Date
- 2008-05-21
- Last Posted Date
- 2016-01-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2600
- Registration Number
- NCT00681122
- Locations
- 🇻🇪
Research Site, Valencia, Estado Carabobo, Venezuela